UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call
10 Novembro 2023 - 6:56PM
Business Wire
Pulse Biosciences will host a conference call at 9:00 am PT /
12:00 pm ET on Monday, November 13, 2023
Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company
primarily focused on leveraging its novel and proprietary CellFX
Nanosecond Pulsed Field Ablation (nsPFA) technology for the
treatment of atrial fibrillation, today announced it will now
report financial results for the third quarter of 2023 before
market opens on Monday, November 13, 2023. Company management will
now host a corresponding conference call beginning at 9:00am PT /
12:00pm ET.
Investors interested in listening to the conference call may do
so by dialing 1-877-704-4453 for domestic callers or 1-201-389-0920
for international callers. A live and recorded webcast of the event
will be available at http://investors.pulsebiosciences.com/.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company
committed to health innovation that has the potential to improve
the quality of life for patients. The Company’s proprietary CellFX
Nanosecond Pulsed Field Ablation (nsPFA) technology delivers
nanosecond pulses of electrical energy to non-thermally clear cells
while sparing adjacent noncellular tissue. The Company is actively
pursuing the development of its CellFX nsPFA technology for use in
the treatment of atrial fibrillation and in a select few other
markets where CellFX nsPFA could have a profound positive impact on
healthcare for both patients and providers.
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA
and the stylized logos are among the trademarks and/or registered
trademarks of Pulse Biosciences, Inc. in the United States and
other countries.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231110463261/en/
Investor Contacts: Pulse Biosciences Kevin Danahy, CEO
510.241.1077 IR@pulsebiosciences.com
or Gilmartin Group Philip Trip Taylor 415.937.5406
philip@gilmartinir.com
Pulse Biosciences (NASDAQ:PLSE)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Pulse Biosciences (NASDAQ:PLSE)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
